Fragment‐Based Discovery of a Dual pan‐RET/VEGFR2 Kinase Inhibitor Optimized for Single‐Agent Polypharmacology

Publisher: John Wiley & Sons Inc

E-ISSN: 1521-3757|127|30|8841-8845

ISSN: 0044-8249

Source: ANGEWANDTE CHEMIE, Vol.127, Iss.30, 2015-07, pp. : 8841-8845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract